Bioequivalence Study of Baricitinib From Barcimiant 4 mg Film Coated Tablets (Horus Pharma, Egypt) and Olumiant 4 mg Film Coated Tablets (Eli Lilly Nederland B.V., The Netherlands)
Clinical trial NCT05006768 · COMPLETED
Trial details
- NCT number
- NCT05006768
- Sponsor
- Genuine Research Center, Egypt
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2021-06-03
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.